OPTN/SRTR 2012 Annual Data Report: Lung

M. Valapour, M. A. Skeans, B. M. Heubner, J. M. Smith, M. A. Schnitzler, Marshall I Hertz, L. B. Edwards, J. J. Snyder, A. K. Israni, Bert L Kasiske

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

Lung transplants are increasingly used as treatment for end-stage lung diseases not amenable to other medical and surgical therapies. Lungs are allocated to adult and adolescent transplant candidates on the basis of age, geography, blood type compatibility, and the Lung Allocation Score, which reflects risk of wait-list mortality and probability of posttransplant survival. The overall median waiting time in 2012 was 4 months, and 65.3% of candidates underwent transplant within 1 year of listing; however, this proportion varied greatly by donation service area. Unadjusted median survival of lung transplant recipients was 5.3 years in 2012, and median survival conditional on living for 1 year posttransplant was 6.7 years. Among pediatric lung candidates in 2012, 32.1% were wait-listed for less than 1 year, 17.9% for 1 to less than 2 years, 16.7% for 2 to less than 4 years, and 33.3% for 4 or more years. Both graft and patient survival have continued to improve; survival rates for recipients aged 6-11 years are better than for younger recipients. Compared with recipients of other solid organ transplants, lung transplant recipients experienced the highest rates of rehospitalization for transplant complications: 43.7 per 100 patients in year 1 and 36.0 in year 2.

Original languageEnglish (US)
Pages (from-to)139-165
Number of pages27
JournalAmerican Journal of Transplantation
Volume14
Issue numberSUPPL. 1
DOIs
StatePublished - Feb 10 2014

Fingerprint

Annual Reports
Lung
Transplants
Geography
Survival
Graft Survival
Lung Diseases
Survival Rate
Pediatrics
Mortality
Therapeutics

Keywords

  • End-stage lung diseases
  • Lung Allocation Score
  • Lung transplant
  • Organ allocation
  • Transplant outcomes

Cite this

Valapour, M., Skeans, M. A., Heubner, B. M., Smith, J. M., Schnitzler, M. A., Hertz, M. I., ... Kasiske, B. L. (2014). OPTN/SRTR 2012 Annual Data Report: Lung. American Journal of Transplantation, 14(SUPPL. 1), 139-165. https://doi.org/10.1111/ajt.12584

OPTN/SRTR 2012 Annual Data Report : Lung. / Valapour, M.; Skeans, M. A.; Heubner, B. M.; Smith, J. M.; Schnitzler, M. A.; Hertz, Marshall I; Edwards, L. B.; Snyder, J. J.; Israni, A. K.; Kasiske, Bert L.

In: American Journal of Transplantation, Vol. 14, No. SUPPL. 1, 10.02.2014, p. 139-165.

Research output: Contribution to journalArticle

Valapour, M, Skeans, MA, Heubner, BM, Smith, JM, Schnitzler, MA, Hertz, MI, Edwards, LB, Snyder, JJ, Israni, AK & Kasiske, BL 2014, 'OPTN/SRTR 2012 Annual Data Report: Lung', American Journal of Transplantation, vol. 14, no. SUPPL. 1, pp. 139-165. https://doi.org/10.1111/ajt.12584
Valapour M, Skeans MA, Heubner BM, Smith JM, Schnitzler MA, Hertz MI et al. OPTN/SRTR 2012 Annual Data Report: Lung. American Journal of Transplantation. 2014 Feb 10;14(SUPPL. 1):139-165. https://doi.org/10.1111/ajt.12584
Valapour, M. ; Skeans, M. A. ; Heubner, B. M. ; Smith, J. M. ; Schnitzler, M. A. ; Hertz, Marshall I ; Edwards, L. B. ; Snyder, J. J. ; Israni, A. K. ; Kasiske, Bert L. / OPTN/SRTR 2012 Annual Data Report : Lung. In: American Journal of Transplantation. 2014 ; Vol. 14, No. SUPPL. 1. pp. 139-165.
@article{2f41af4ca725444ba62eaeb5bcfba4ba,
title = "OPTN/SRTR 2012 Annual Data Report: Lung",
abstract = "Lung transplants are increasingly used as treatment for end-stage lung diseases not amenable to other medical and surgical therapies. Lungs are allocated to adult and adolescent transplant candidates on the basis of age, geography, blood type compatibility, and the Lung Allocation Score, which reflects risk of wait-list mortality and probability of posttransplant survival. The overall median waiting time in 2012 was 4 months, and 65.3{\%} of candidates underwent transplant within 1 year of listing; however, this proportion varied greatly by donation service area. Unadjusted median survival of lung transplant recipients was 5.3 years in 2012, and median survival conditional on living for 1 year posttransplant was 6.7 years. Among pediatric lung candidates in 2012, 32.1{\%} were wait-listed for less than 1 year, 17.9{\%} for 1 to less than 2 years, 16.7{\%} for 2 to less than 4 years, and 33.3{\%} for 4 or more years. Both graft and patient survival have continued to improve; survival rates for recipients aged 6-11 years are better than for younger recipients. Compared with recipients of other solid organ transplants, lung transplant recipients experienced the highest rates of rehospitalization for transplant complications: 43.7 per 100 patients in year 1 and 36.0 in year 2.",
keywords = "End-stage lung diseases, Lung Allocation Score, Lung transplant, Organ allocation, Transplant outcomes",
author = "M. Valapour and Skeans, {M. A.} and Heubner, {B. M.} and Smith, {J. M.} and Schnitzler, {M. A.} and Hertz, {Marshall I} and Edwards, {L. B.} and Snyder, {J. J.} and Israni, {A. K.} and Kasiske, {Bert L}",
year = "2014",
month = "2",
day = "10",
doi = "10.1111/ajt.12584",
language = "English (US)",
volume = "14",
pages = "139--165",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",
number = "SUPPL. 1",

}

TY - JOUR

T1 - OPTN/SRTR 2012 Annual Data Report

T2 - Lung

AU - Valapour, M.

AU - Skeans, M. A.

AU - Heubner, B. M.

AU - Smith, J. M.

AU - Schnitzler, M. A.

AU - Hertz, Marshall I

AU - Edwards, L. B.

AU - Snyder, J. J.

AU - Israni, A. K.

AU - Kasiske, Bert L

PY - 2014/2/10

Y1 - 2014/2/10

N2 - Lung transplants are increasingly used as treatment for end-stage lung diseases not amenable to other medical and surgical therapies. Lungs are allocated to adult and adolescent transplant candidates on the basis of age, geography, blood type compatibility, and the Lung Allocation Score, which reflects risk of wait-list mortality and probability of posttransplant survival. The overall median waiting time in 2012 was 4 months, and 65.3% of candidates underwent transplant within 1 year of listing; however, this proportion varied greatly by donation service area. Unadjusted median survival of lung transplant recipients was 5.3 years in 2012, and median survival conditional on living for 1 year posttransplant was 6.7 years. Among pediatric lung candidates in 2012, 32.1% were wait-listed for less than 1 year, 17.9% for 1 to less than 2 years, 16.7% for 2 to less than 4 years, and 33.3% for 4 or more years. Both graft and patient survival have continued to improve; survival rates for recipients aged 6-11 years are better than for younger recipients. Compared with recipients of other solid organ transplants, lung transplant recipients experienced the highest rates of rehospitalization for transplant complications: 43.7 per 100 patients in year 1 and 36.0 in year 2.

AB - Lung transplants are increasingly used as treatment for end-stage lung diseases not amenable to other medical and surgical therapies. Lungs are allocated to adult and adolescent transplant candidates on the basis of age, geography, blood type compatibility, and the Lung Allocation Score, which reflects risk of wait-list mortality and probability of posttransplant survival. The overall median waiting time in 2012 was 4 months, and 65.3% of candidates underwent transplant within 1 year of listing; however, this proportion varied greatly by donation service area. Unadjusted median survival of lung transplant recipients was 5.3 years in 2012, and median survival conditional on living for 1 year posttransplant was 6.7 years. Among pediatric lung candidates in 2012, 32.1% were wait-listed for less than 1 year, 17.9% for 1 to less than 2 years, 16.7% for 2 to less than 4 years, and 33.3% for 4 or more years. Both graft and patient survival have continued to improve; survival rates for recipients aged 6-11 years are better than for younger recipients. Compared with recipients of other solid organ transplants, lung transplant recipients experienced the highest rates of rehospitalization for transplant complications: 43.7 per 100 patients in year 1 and 36.0 in year 2.

KW - End-stage lung diseases

KW - Lung Allocation Score

KW - Lung transplant

KW - Organ allocation

KW - Transplant outcomes

UR - http://www.scopus.com/inward/record.url?scp=84893223159&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893223159&partnerID=8YFLogxK

U2 - 10.1111/ajt.12584

DO - 10.1111/ajt.12584

M3 - Article

C2 - 24373171

AN - SCOPUS:84893223159

VL - 14

SP - 139

EP - 165

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

IS - SUPPL. 1

ER -